Next |
home / stock / nvcr / nvcr message board
Subject | By | Source | When |
---|---|---|---|
You go to $NWBO MB and thumsy up | KIPK | investorshub | 04/28/2023 3:58:51 PM |
LOL - THI HAT HAS NO CHNCE. THE | KIPK | investorshub | 04/28/2023 1:02:50 PM |
$NVCR has a great chance of retaking the | whosleftholdindabag | investorshub | 04/27/2023 9:21:22 PM |
Won't make a diff. SP will continue to | KIPK | investorshub | 04/27/2023 12:44:45 PM |
Results of LUNAR at ASCO. Also, nine other | jondoeuk | investorshub | 04/26/2023 6:00:33 PM |
LOL - Sounds like Jonk to me | KIPK | investorshub | 04/21/2023 12:16:28 PM |
LOL - NoCure has no future - Just | KIPK | investorshub | 04/21/2023 12:15:07 PM |
Crash, $NVCR has a MUCH brighter future than | whosleftholdindabag | investorshub | 04/20/2023 10:42:10 PM |
The PR https://www.businesswire.com/news/home/20230413005882/en/Novocure-Announc | jondoeuk | investorshub | 04/14/2023 8:26:19 PM |
As someone once said, ''Never argue with an | jondoeuk | investorshub | 04/13/2023 10:07:17 PM |
Novocure has no product that works. | CrashOverride | investorshub | 04/13/2023 3:52:21 PM |
Rarely do I capitalize on buying at the | whosleftholdindabag | investorshub | 04/13/2023 12:15:18 PM |
Opinion (bad one) And for someone who is always | Legend431 | investorshub | 03/28/2023 1:57:48 PM |
Optune, junk science! | CrashOverride | investorshub | 03/28/2023 3:53:06 AM |
Can you believe this 18 months ago was | Zadie420 | investorshub | 03/19/2023 4:32:01 PM |
You missing the fact that the tinfoil is | KIPK | investorshub | 03/19/2023 1:52:28 PM |
Quoting AACR the only one to publish Adam | The Danish Dude | investorshub | 03/19/2023 10:54:08 AM |
Also, | jondoeuk | investorshub | 03/18/2023 3:49:51 AM |
AACR abstracts (the event is next month). | jondoeuk | investorshub | 03/18/2023 3:19:48 AM |
Simply put, no. | jondoeuk | investorshub | 03/17/2023 11:46:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company’s financial results for the three...
2024-06-13 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-04 10:45:03 ET Wells Fargo analyst issues NEUTRAL recommendation for NVCR on June 4, 2024 09:01AM ET. The previous analyst recommendation was Neutral. NVCR was trading at $24.055 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...